BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
38.00
-1.00 (-2.56%)
Nov 18, 2026, 10:31 AM JST

TYO:4594 Revenue

In the fiscal year ending March 31, 2026, BrightPath Biotherapeutics had annual revenue of 84.00K JPY, down -92.59%. BrightPath Biotherapeutics had revenue of 51.00K in the quarter ending March 31, 2026, a decrease of -95.11%. That makes BrightPath Biotherapeutics the 47,738th largest company in the world by revenue and 3,879th in Japan.

Revenue
84.00K
Revenue Growth
-92.59%
P/S Ratio
64,485.21
Revenue / Employee
2.00K
Employees
42
Market Cap
5.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202684.00K-1.05M-92.59%
Mar 31, 20251.13M1.06M1,473.61%
Mar 31, 202472.00K-353.93M-99.98%
Mar 31, 2018354.00M-175.00M-33.08%
Mar 31, 2017529.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.